Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sorting nexin-19 (SNX19) is a member of the sorting nexin family, proteins involved in phosphoinositide-mediated vesicle trafficking. SNX19 localizes predominantly to the endoplasmic reticulum and functions to tether endolysosomes to the ER, thereby restricting their motility and maintaining their perinuclear positioning in cells. It contains two N-terminal transmembrane domains that anchor it to the ER, and a PX domain responsible for binding phosphatidylinositol 3-phosphate on endolysosomal membranes. Additional domains regulate its interaction with endolysosomes. In pancreatic beta cells, SNX19 helps maintain insulin-containing vesicle integrity and influences insulin secretion. Mutations or dysfunction in SNX19 are associated with disorders such as spinocerebellar ataxia and immunodeficiency, and SNX family proteins are broadly implicated in cardiovascular diseases via endocytic and signaling pathway regulation[1][2][3][4][5].
Not applicable; no drugs are reported to directly target SNX19. Its mechanism relates to vesicle trafficking, ER-endolysosome tethering, and phosphatidylinositol 3-phosphate binding[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sorting nexin-19 (SNX19).